Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.

Ashraf, Amir Reza et al.·Journal of medical Internet research·2024·
RPEP-077782024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.
Published In:
Journal of medical Internet research, 26, e65440 (2024)
Database ID:
RPEP-07778

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07778·https://rethinkpeptides.com/research/RPEP-07778

APA

Ashraf, Amir Reza; Mackey, Tim Ken; Vida, Róbert György; Kulcsár, Győző; Schmidt, János; Balázs, Orsolya; Domián, Bálint Márk; Li, Jiawei; Csákó, Ibolya; Fittler, András. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.. Journal of medical Internet research, 26, e65440. https://doi.org/10.2196/65440

MLA

Ashraf, Amir Reza, et al. "Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.." Journal of medical Internet research, 2024. https://doi.org/10.2196/65440

RethinkPeptides

RethinkPeptides Research Database. "Multifactor Quality and Safety Analysis of Semaglutide Produ..." RPEP-07778. Retrieved from https://rethinkpeptides.com/research/ashraf-2024-multifactor-quality-and-safety

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.